BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 7794589)

  • 1. The social costs of anxiety disorders.
    Leon AC; Portera L; Weissman MM
    Br J Psychiatry Suppl; 1995 Apr; (27):19-22. PubMed ID: 7794589
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Costs of nine common mental disorders: implications for curative and preventive psychiatry.
    Smit F; Cuijpers P; Oostenbrink J; Batelaan N; de Graaf R; Beekman A
    J Ment Health Policy Econ; 2006 Dec; 9(4):193-200. PubMed ID: 17200596
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Sociodemographic profiles, addictive and mental comorbidity in cannabis users in an outpatient specific setting].
    Guillem E; Pelissolo A; Vorspan F; Bouchez-Arbabzadeh S; Lépine JP
    Encephale; 2009 Jun; 35(3):226-33. PubMed ID: 19540408
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Anxiety disorders in private practice psychiatric out-patients: prevalence, comorbidity and burden (DELTA study)].
    Pélissolo A; André C; Chignon JM; Dutoit D; Martin P; Richard-Berthe C; Tignol J
    Encephale; 2002; 28(6 Pt 1):510-9. PubMed ID: 12506263
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cost-outcome of anxiety treatment intervention in primary care in Hungary.
    Zámbori J; Szádóczky E; Rózsa S; Füredi J
    J Ment Health Policy Econ; 2002 Sep; 5(3):115-20. PubMed ID: 12728198
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Economic costs of anxiety disorders.
    DuPont RL; Rice DP; Miller LS; Shiraki SS; Rowland CR; Harwood HJ
    Anxiety; 1996; 2(4):167-72. PubMed ID: 9160618
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The epidemiology of anxiety disorders: prevalence and societal costs.
    Lépine JP
    J Clin Psychiatry; 2002; 63 Suppl 14():4-8. PubMed ID: 12562112
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The economic burden of affective disorders.
    Rice DP; Miller LS
    Br J Psychiatry Suppl; 1995 Apr; (27):34-42. PubMed ID: 7794592
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Costs and offset effect in panic disorders.
    Salvador-Carulla L; Seguí J; Fernández-Cano P; Canet J
    Br J Psychiatry Suppl; 1995 Apr; (27):23-8. PubMed ID: 7794590
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Disability and poor quality of life associated with comorbid anxiety disorders and physical conditions.
    Sareen J; Jacobi F; Cox BJ; Belik SL; Clara I; Stein MB
    Arch Intern Med; 2006 Oct; 166(19):2109-16. PubMed ID: 17060541
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Medical and productivity costs of anxiety disorders: case control study.
    Marciniak M; Lage MJ; Landbloom RP; Dunayevich E; Bowman L
    Depress Anxiety; 2004; 19(2):112-20. PubMed ID: 15022146
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human and economic burden of generalized anxiety disorder.
    Hoffman DL; Dukes EM; Wittchen HU
    Depress Anxiety; 2008; 25(1):72-90. PubMed ID: 17146763
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dose-response relationship between number of comorbid anxiety disorders in adolescent bipolar/unipolar disorders, and psychosis, suicidality, substance abuse and familiality.
    Dilsaver SC; Akiskal HS; Akiskal KK; Benazzi F
    J Affect Disord; 2006 Dec; 96(3):249-58. PubMed ID: 16904187
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Health economics and cost implications of anxiety and other mental disorders in the United States.
    Rice DP; Miller LS
    Br J Psychiatry Suppl; 1998; (34):4-9. PubMed ID: 9829010
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Generalized anxiety disorder: prevalence, burden, and cost to society.
    Wittchen HU
    Depress Anxiety; 2002; 16(4):162-71. PubMed ID: 12497648
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The cost of treating anxiety: the medical and demographic correlates that impact total medical costs.
    Marciniak MD; Lage MJ; Dunayevich E; Russell JM; Bowman L; Landbloom RP; Levine LR
    Depress Anxiety; 2005; 21(4):178-84. PubMed ID: 16075454
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Implementation of social services for the chronically mentally ill in a Polish mental health district: consequences for service use and costs.
    Zaluska M; Suchecka D; Traczewska Z; Paszko J
    J Ment Health Policy Econ; 2005 Mar; 8(1):37-44. PubMed ID: 15870484
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Co-occurrence of 12-month mood and anxiety disorders and personality disorders in the US: results from the national epidemiologic survey on alcohol and related conditions.
    Grant BF; Hasin DS; Stinson FS; Dawson DA; Patricia Chou S; June Ruan W; Huang B
    J Psychiatr Res; 2005 Jan; 39(1):1-9. PubMed ID: 15504418
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comorbid substance and mental disorders among rural Americans: results from the National Comorbidity Survey.
    Simmons LA; Havens JR
    J Affect Disord; 2007 Apr; 99(1-3):265-71. PubMed ID: 16978706
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The relationship between anxiety disorders and physical disorders in the U.S. National Comorbidity Survey.
    Sareen J; Cox BJ; Clara I; Asmundson GJ
    Depress Anxiety; 2005; 21(4):193-202. PubMed ID: 16075453
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.